Related Experiment Video
Updated: Jun 25, 2026

Measuring In Vivo Changes in Extracellular Neurotransmitters During Naturally Rewarding Behaviors in Female Syrian Hamsters
Published on: September 12, 2017
Melatonin Receptor Sites in the Syrian Hamster Brain and Pituitary. Localization and Characterization Using
L M Williams1, P J Morgan, M H Hastings
1Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen AB2 9SB, UK.
Abstract:
Abstract A high-affinity, discretely localized melatonin receptor has been characterized and mapped within the brain and pituitary of the Syrian hamster using the high specific activity ligand [(125)|]iodomelatonin and a combination of in vitro autoradiography and membrane homogenate receptor assays. Specific binding of radioligand was found in regions of the epithalamus and hypothalamus in the brain and the pars tuberalis of the pituitary. Excitatory amino-acid lesions destroyed [(125)|]iodomelatonin binding within the brain, demonstrating that binding sites are located on neurons. Analysis of [(125)|]iodomelatonin binding to membrane homogenates of the pars tuberalis revealed a linear relationship between specific ligand binding and the amount of tissue. The time-course of specific binding at 37 degrees C reached equilibrium after 30 min and remained stable thereafter. The addition of increasing concentrations of [(125)|]iodomelatonin alone and in the presence of 1 muM melatonin showed that specific binding reached equilibrium at 80 to 100 pM. Analysis of the saturation isotherm using a one-site binding model was consistent with a single receptor site with a K(d) of 29.3 (+/-5.9 SEM) pM and B(max) of 2.54 (+/-0.19 SEM) fmol/mg protein.
Related Concept Videos
The Pineal Gland
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

